Hemostats Market Report 2026

Hemostats Market Overview

• Hemostats market size has reached to $3.56 billion in 2025 • Expected to grow to $5.02 billion in 2030 at a compound annual growth rate (CAGR) of 7.2% • Growth Driver: Surgical Precision Spurs Surge Hemostat Market Surges Amidst Rising Surgical Procedures • Market Trend: Strategic Collaborations And Partnerships Driving Expansion In The Hemostat Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Hemostats Market?

Hemostat refers to a surgical tool used in many surgical procedures that helps to treat or compress bleeding vessels while doing surgeries. It also helps to hold the deeper regions of the wound that can be visualized by using this equipment. The various types of hemostats are thrombin-based hemostats, oxidized regenerated cellulose-based hemostats, combination hemostats, gelatin-based hemostats, and collagen-based hemostats. Thrombin-based hemostats are used in conjunction with or as an alternative to traditional surgical techniques to control and reduce blood loss during surgical procedures. It refers to an enzyme that breaks down fibrinogen into fibrin. Blood that has been exposed to thrombin directly clots it. Topical (bovine) thrombin (thrombin-jmi), topical (human) thrombin (evithrom), and topical (recombinant) thrombin are the active hemostats (recothrom). The various products include active hemostats, passive hemostats, combination hemostats, and other products. The various types of formulation include matrix and gel hemostats, sheet and pad hemostats, sponge hemostats, and powder hemostats. The various types of application include orthopedic surgery, general surgery, neurological surgery, cardiovascular surgery, reconstructive surgery, gynecological surgery, and other applications.

What Is The Hemostats Market Growth Forecast?

The hemostats market size is expected to see strong growth in the next few years. It will grow to $5.02 billion in 2030 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to increasing focus on patient safety outcomes, rising demand for faster surgical recovery, expansion of advanced trauma care facilities, growing innovation in bioactive hemostatic materials, increasing adoption of specialty surgical products. Major trends in the forecast period include increasing use of advanced combination hemostats, rising adoption of ready-to-use hemostatic agents, growing demand for rapid bleeding control solutions, expansion of biocompatible and absorbable products, enhanced focus on surgical efficiency and safety.

What Are The Drivers Of The Hemostats Market?

An increase in surgical procedures is expected to propel the growth of the hemostat market going forward. Surgical procedures refer to all forms of invasive treatments that are used on a person to investigate or treat a pathological condition. Hemostats are essential for surgical procedures as they are used to prevent blood loss while performing surgery. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based non-profit organization, minimally invasive procedures increased by 7% in 2023, outpacing the growth rate of surgical procedures by 2%. Hand surgeries such as carpal tunnel, arthritis, and trigger finger totaled 207,887 procedures, a 2% rise from 2022. Therefore, an increase in surgical procedures is driving the growth of the hemostat industry. The increasing prevalence of trauma cases is expected to propel the growth of the haemostat market going forward. A trauma case refers to any medical situation involving injury caused by an external force that requires urgent evaluation and treatment. The rise in trauma cases is driven by increased road accidents, as higher traffic volume and unsafe driving behaviours lead to more severe injuries requiring urgent care. Hemostats help trauma cases by rapidly controlling bleeding at the injury site, allowing clinicians to stabilize patients more quickly and improve overall survival outcomes. For instance, in October 2024, according to the Alaska Department of Health, a US-based government agency, in 2023, approximately 3,373 people in Alaska sustained traumatic brain injuries (TBI), including both fatal cases and non-fatal injuries that were treated and released from hospitals or emergency departments (EDs). Therefore, the increasing prevalence of trauma cases is driving the growth of the haemostat market.

Key Players In The Global Hemostats Market

Major companies operating in the hemostats market are B. Braun Melsungen AG, Baxter International Inc., Integra LifeSciences Corporation, Becton Dickinson and Company, Teleflex Incorporated, Medtronic PLC, Hemostasis LLC, Stryker Corporation, Advanced Medical Solutions Group PLC, Samyang Holdings Corporation, Gelita Medical GmbH, CryoLife Inc., CuraMedical B.V., Meril Life Sciences Pvt. Ltd., Beijing Datsing Bio-Tech Co. Ltd., Zhonghui Shengxi (Beijing) Medical Technology Co. Ltd., Biotemed Inc., Biom'up SA, Shandong Foryou Medical Devices Co. Ltd., Z-Medica LLC, Anika Therapeutics Inc.

Global Hemostats Market Trends and Insights

Major companies are strategically entering partnerships and collaborations with start-ups and mid-sized companies in the Hemostat market to broaden the products and services offered by the company. Strategic collaborations and partnership agreements help companies expand their existing product portfolio and geographical reach. For instance, In May 2023, Japan based manufacturer of optics and reprography products, Olympus expands Endoclot partnership with US-based a medical device company, Endoclot to launch hemostatic agents. The addition of their solutions to the portfolio allows Olympus to contribute to safe treatment in gastrointestinal procedures. The aim of this partnership is to improve patient outcomes and hereby elevate the standard of care.

What Defines the Hemostats Market?

The hemostat market consists of sales of cellulose based and thrombin-based hemostats. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Hemostats Market Report 2026?

The hemostats market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the hemostats industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.